TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.
IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...
The founder of Ginger Ah, China's first lingerie brand to develop both bras and the artificial breasts, says they struggle to ...
An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...
Women with breast cancer who receive chemotherapy experienced a lasting decline in physical health, a new study found.
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.
Less than two months ago, 52-year-old Oklahoma State Representative Melissa Provenzano underwent a mastectomy for stage one ...
Breast cancer is the second leading cause of cancer deaths in women in the U.S., killing more than 42,000 last year ...
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
Six degrees of separation? Olivia Munn's breast cancer diagnosis leads to Inside Edition reporter's discovery. This is how it ...
Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback